Plasmin has been shown to degrade major components of the ECM such as collagens and fibronectin, suggesting that stimulation of plasmin activity is a promising strategy for the treatment of pulmonary fibrosis (Deryugina and Quigley 2012; Papp et al. 1987; Pins et al. 2000). The gene discussed is PLG; the disease is pulmonary fibrosis.